Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

SMS Pharmaceuticals Management Change

SMS Pharmaceuticals has re-appointed Mr. Ramesh Babu Potluri as Executive Director for a 60-month term effective October 1, 2026.

Source

NSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

SMS Pharmaceuticals Ltd: key numbers

Share price
₹525.50
Market cap
₹4,659 Cr
Revenue (annual)
₹886.9 Cr
Net profit (annual)
₹102.0 Cr
P/E (TTM)
39.8×Sector 37.9×
Promoter holding
68.07%+0.00% QoQ
FII holding
1.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from SMS Pharmaceuticals Ltd

All →
13:26 IST NSE
Financial Results

SMS Pharmaceuticals Q2 FY27 Results: Net Profit ₹39.9 Cr, Up 57.7% YoY

SMS Pharmaceuticals Ltd reported revenue from operations of ₹316.1 Cr (+30.4% YoY) and net profit of ₹39.9 Cr (+57.7% YoY) for Q2 FY27.

Key figure
Net profit ₹39.9 Cr · +57.7% YoY

Other management change announcements

All →